This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Michael Karle: Innovator in Therapeutic Agents
Introduction
Michael Karle is a notable inventor based in Molndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents.
Latest Patents
Karle holds a patent for "Isoxazol-3(2H)-one analogs as therapeutic agents - or a pharmaceutically suitable salt thereof." This innovation showcases his commitment to advancing medical science and improving treatment options.
Career Highlights
Currently, Michael Karle is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca reflects his dedication to research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Karle has collaborated with esteemed colleagues, including Daniel Tor Pettersen and Leifeng Cheng. These partnerships have further enhanced his contributions to the field.
Conclusion
Michael Karle's innovative work in therapeutic agents exemplifies the impact of dedicated inventors in the pharmaceutical industry. His patent and collaborations highlight the importance of teamwork in advancing medical research.